Cloud platform solution for easy and accurate quantitative assessment of brain images and for providing clinical decision support in neurological disorders.

Get support to manage the bulk of post COVID 19 patients being evaluated for dementia or Multiple Sclerosis

Up to 4 releases per Year

With cNeuro® you will be able to focus on essential information and automatically obtain a report that enables early diagnosis and efficient management of neurodegenerative diseases

Cloud

computing

Machine

learning

Web-

based

Patient

privacy

Collaborative Solution

cNeuro® cMRI 
Quantitative MRI for radiologists

  • Fully automated cross-sectional and longitudinal analysis of atrophy and lesions with seamless PACS integration.
  • Enhance your workflow and provide detailed report to referring physician.

cNeuro® cDSI 
 Advanced Solution for neurologists

  • Combines imaging findings with other data such as CSF-biomarkers and neuropsychology tests results and compares to a large database of previously diagnosed cases. 
  • Get support to detect disease early, perform differential diagnostics, predict progression and decide whether more testing is needed.

FOR MORE INFORMATION  
Please contact us at
Email: michel@combinostics.com
Phone: +32 497 319565 

OUR OFFICE
Combinostics Oy
Hatanpään valtatie 24
33100 Tampere, FINLAND

Go to article: Home | Balancing function with fashionGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Omnitron Company Insight Go to article: Omnitron Go to article: CombinosticsGo to article: Watlow Company InsightGo to article: WatlowGo to article: FortisGo to article: CommentGo to article: Mobile health applications can help with cognitive function and mental healthGo to article: Digital therapeutics are not a panacea for the global mental health crisisGo to article: FDA authorises the first AI-based software to detect prostate cancerGo to article: Lenzing Plastics Company InsightGo to article: Lenzing PlasticsGo to article: AccumoldGo to article: On Line ControlsGo to article: SiemensGo to article: In DepthGo to article: Equipment aesthetics: the companies improving mobility aid designGo to article: Counterfeit medical devices: on the rise during Covid-19?Go to article: NuroKor Bioelectronics: can electricity replace opioids?Go to article: Paragonix: the next generation of donor organ transportGo to article: Can tech solve the UK radiology staffing shortage?Go to article: How hospitals and the medtech sector are tackling the climate crisisGo to article: HoowakiGo to article: Frankfurt Laser CompanyGo to article: ProByLas Go to article: Sandvik Company InsightGo to article: Sandvik Go to article: VartaGo to article: In DataGo to article: Data: North America is seeing a hiring boom in medical industry ESG rolesGo to article: The medical industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: Custom Wire Company Insight Go to article: Custom WireGo to article: RegPakGo to article: SemecsGo to article: oncgnosticsGo to article: EventsGo to article: Next Issue